Table 3 Immunoreactivity of VEGF, and the number of patients
From: Vascular endothelial growth factor in children with neuroblastoma: a retrospective analysis
Category | Number of patients (%) | alive/dead |
|---|---|---|
Percentage of positive | ||
tumour cells (P) | ||
<1% | 2 (3.6%) | 2/0 |
1-25% | 25 (44.6%) | 17/8 |
26-50% | 18 (32.1%) | 10/8 |
51-75% | 7 (12.5%) | 4/3 |
76-100% | 4 (7.1%) | 2/2 |
Staining intensity (I) | ||
Negative | 2 (3.6%) | 2/0 |
Weak | 11 (19.6%) | 10/1 |
Moderate | 24 (42.9%) | 12/12 |
Strong | 19 (33.9%) | 11/8 |
Expression score (P+I) | ||
Low (0-2) | 12 (21.4%) | 12/0 |
High (3-7) | 44 (78.6%) | 23/21 |